Insider Transactions in Q1 2022 at Travelers Companies, Inc. (TRV)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Elizabeth Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
184
+3.38%
|
$33,488
$182.73 P/Share
|
|
Feb 28
2022
|
Douglas K Russell SVP, Corp Contr & Treasurer |
SELL
Open market or private sale
|
Direct |
1,161
-6.21%
|
$199,692
$172.0 P/Share
|
|
Feb 23
2022
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,632
-15.45%
|
$450,072
$171.5 P/Share
|
|
Feb 23
2022
|
Andy F Bessette EVP and Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,844
+25.54%
|
-
|
|
Feb 23
2022
|
Daniel S. Frey EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,214
-42.76%
|
$720,594
$171.5 P/Share
|
|
Feb 23
2022
|
Daniel S. Frey EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,044
+47.86%
|
-
|
|
Feb 23
2022
|
William H Heyman Vice Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
7,849
-3.03%
|
$1,342,179
$171.5 P/Share
|
|
Feb 23
2022
|
William H Heyman Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
14,193
+5.19%
|
-
|
|
Feb 23
2022
|
Avrohom J. Kess Vice Chmn & Chief Legal Off |
SELL
Payment of exercise price or tax liability
|
Direct |
7,849
-20.2%
|
$1,342,179
$171.5 P/Share
|
|
Feb 23
2022
|
Avrohom J. Kess Vice Chmn & Chief Legal Off |
BUY
Grant, award, or other acquisition
|
Direct |
14,193
+26.75%
|
-
|
|
Feb 23
2022
|
Michael Frederick Klein EVP & President, Personal Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,213
-31.63%
|
$720,423
$171.5 P/Share
|
|
Feb 23
2022
|
Michael Frederick Klein EVP & President, Personal Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
9,044
+40.44%
|
-
|
|
Feb 23
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,752
-22.39%
|
$299,592
$171.5 P/Share
|
|
Feb 23
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
3,757
+32.44%
|
-
|
|
Feb 23
2022
|
Diane Kurtzman EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-18.81%
|
$68,742
$171.5 P/Share
|
|
Feb 23
2022
|
Diane Kurtzman EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,113
+34.25%
|
-
|
|
Feb 23
2022
|
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,271
-45.21%
|
$559,341
$171.5 P/Share
|
|
Feb 23
2022
|
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,235
+50.0%
|
-
|
|
Feb 23
2022
|
Maria Olivo EVP, Strat Dev & Pres Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
3,621
-3.54%
|
$619,191
$171.5 P/Share
|
|
Feb 23
2022
|
Maria Olivo EVP, Strat Dev & Pres Intl |
BUY
Grant, award, or other acquisition
|
Direct |
7,235
+6.61%
|
-
|
|
Feb 23
2022
|
David Donnay Rowland EVP & Co-Chief Invest. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,028
-12.48%
|
$175,788
$171.5 P/Share
|
|
Feb 23
2022
|
David Donnay Rowland EVP & Co-Chief Invest. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,254
+21.49%
|
-
|
|
Feb 23
2022
|
Douglas K Russell SVP, Corp Contr & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
968
-4.92%
|
$165,528
$171.5 P/Share
|
|
Feb 23
2022
|
Douglas K Russell SVP, Corp Contr & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,129
+9.77%
|
-
|
|
Feb 23
2022
|
Alan D Schnitzer Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,702
-12.19%
|
$4,737,042
$171.5 P/Share
|
|
Feb 23
2022
|
Alan D Schnitzer Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,092
+18.06%
|
-
|
|
Feb 23
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,543
-19.79%
|
$776,853
$171.5 P/Share
|
|
Feb 23
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
9,739
+29.79%
|
-
|
|
Feb 23
2022
|
Daniel Tei Hwa Yin EVP & Co-Chief Invest. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,136
-2.37%
|
$194,256
$171.5 P/Share
|
|
Feb 23
2022
|
Daniel Tei Hwa Yin EVP & Co-Chief Invest. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,254
+4.5%
|
-
|
|
Feb 15
2022
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Bona fide gift
|
Direct |
584
-4.96%
|
-
|
|
Feb 09
2022
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.81%
|
$348,000
$174.12 P/Share
|
|
Feb 09
2022
|
William H Heyman Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.8%
|
$236,000
$118.78 P/Share
|
|
Feb 08
2022
|
Alan L Beller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.58%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Janet M Dolan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.02%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Patricia Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.57%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
William J Kane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+4.81%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Thomas B Leonardi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+32.52%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Clarence Otis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+7.59%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Elizabeth Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+17.12%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Philip T Ruegger Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.7%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Rafael Santana Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+50.0%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Todd C Schermerhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+9.48%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Laurie J Thomsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+1.85%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Bridget A Van Kralingen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+50.0%
|
$179,396
$172.5 P/Share
|
|
Feb 08
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
SELL
Open market or private sale
|
Direct |
43,000
-76.49%
|
$7,353,000
$171.85 P/Share
|
|
Feb 08
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
43,000
+43.34%
|
$4,558,000
$106.03 P/Share
|
|
Feb 04
2022
|
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer |
SELL
Open market or private sale
|
Direct |
3,115
-100.0%
|
$535,780
$172.52 P/Share
|
|
Feb 03
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
SELL
Open market or private sale
|
Direct |
10,860
-72.75%
|
$1,878,780
$173.28 P/Share
|
|
Feb 03
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,860
+42.11%
|
$1,151,160
$106.03 P/Share
|